SCHEMBL5842867

SCHEMBL5842867

COc1ccc(OC(=O)CN)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
GAA P10253 3/20 0.56
KMT2A Q03164 3/20 0.53
HSD17B10 Q99714 2/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
PARP10 Q53GL7 2/20 0.50
PARP1 P09874 1/20 0.50
PARP2 Q9UGN5 1/20 0.50
PARP4 Q9UKK3 1/20 0.50
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CA12 O43570 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2592352 0.83 LMNA (0.57) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL5130508 0.83 HTT (0.63) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL8631220 0.83 KMT2A (0.76) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL5973256 0.81 CA1 (0.58) LMNAKMT2AHSD17B10ALDH1A1MAPT
SCHEMBL4643749 0.81 LMNA (0.58) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL11151702 0.81 KMT2A (0.45) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL11773507 0.81 KMT2A (0.45) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL561023 0.81 KMT2A (0.45) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL819434 0.81 KMT2A (0.66) LMNAGAAKMT2AHSD17B10ALDH1A1
SCHEMBL10593101 0.80 KMT2A (0.57) LMNAGAAKMT2AHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110357989-A Tertiary amine photosensitizer, preparation method, comprising its photosensitive polymer combination and photosensitive polymer combination application 常州强力电子新材料股份有限公司 2019-10-22 CN claimed
CN-105294413-B Method for preparing aldehyde/ketone by catalyzing alcohol oxidation with iron salt 浙江工业大学 2017-04-12 CN claimed
CN-118239850-A Synthesis and application of alpha-alkyl glycine derivative 西北师范大学 2024-06-25 CN disclosed
CN-112939883-B Preparation method of polysubstituted 1, 3-oxazolidine compound 兰州大学 2024-01-16 CN disclosed
CN-113004162-B Preparation method of asymmetric gem diaryl acetate compound 苏州大学 2023-05-05 CN disclosed
CN-115838355-A 1, 4-disubstituted piperazine-2, 5-diketone derivative, preparation method and application thereof 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2023-03-24 CN disclosed
WO-2023012437-A1 ANTIBODY-DRUG CONJUGATES MC SAF (FR) 2023-02-09 WO disclosed
WO-2022090520-A1 SITE-SELECTIVE MODIFICATION OF PROTEINS DANMARKS TEKNISKE UNIVERSITET (DK) 2022-05-05 WO disclosed
CN-113004162-A Preparation method of asymmetric geminal diaryl acetate compound 苏州大学 2021-06-22 CN disclosed
CN-112939883-A Preparation method of polysubstituted 1, 3 oxazolidine compound 兰州大学 2021-06-11 CN disclosed
CN-110357989-A Tertiary amine photosensitizer, preparation method, comprising its photosensitive polymer combination and photosensitive polymer combination application 常州强力电子新材料股份有限公司 2019-10-22 CN disclosed
CN-105283439-B The dibenzoylhydrazine of boracic 英特瑞克斯顿股份有限公司 2018-02-02 CN disclosed
CN-105294413-B Method for preparing aldehyde/ketone by catalyzing alcohol oxidation with iron salt 浙江工业大学 2017-04-12 CN disclosed
US-7109243-B2 Inhibitors of cathepsin S IRM LLC (BM) 2006-09-19 US disclosed
CN-1784239-A Protease inhibitors of coronavirus and SARS-COV and use thereof CYTOVIA INC (US) 2006-06-07 CN disclosed
WO-2004084842-A2 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2004-10-07 WO disclosed
US-20040198780-A1 Inhibitors of cathepsin S IRM LLC (BM) 2004-10-07 US disclosed
CN-1473157-A Amide derivatives ֮����ҩ��ʽ���� 2004-02-04 CN disclosed
CN-1297354-A Dipeptide caspase inhibitors and use thereof CYTOVIA INC (US) 2001-05-30 CN disclosed
EP-0254578-A1 Antibiotic intermediates ELI LILLY AND COMPANY (US) 1988-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198780-A1 Inhibitors of cathepsin S CTSS, CTSK, CTSE LMNA 3044/4885GAA 58/4885KMT2A 3983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.